[1]
2017. Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system. Brazilian Journal of Pharmaceutical Sciences. 53, 3 (Jan. 2017), e00178-. DOI:https://doi.org/10.1590/s2175-97902017000300178.